Navigation Links
Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
Date:9/13/2010

PRINCETON, N.J., Sept. 13 /PRNewswire/ -- Soligenix, Inc. (Soligenix or the Company) (OTC Bulletin Board: SNGX), a late-stage biopharmaceutical company, announced today that its President and Chief Executive Officer Christopher J. Schaber, Ph.D. will present a company overview highlighting recent developments at the Rodman & Renshaw 12th Annual Healthcare Conference in New York City.  The presentation will take place on Wednesday, September 15, 2010 at 10:00AM EDT in the Spellman Salon (5th Floor) of the New York Palace Hotel.

The Soligenix presentation will be webcast live and archived for later replay. To access the webcast, please visit the Company's "Investor" page at www.soligenix.com.  A replay of the presentation will be archived for 30 days after the conference at the same location.

About Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host-Disease (GI GVHD), a common and potentially life-threatening complication of hematopoietic cell transplantation. orBec® is currently the subject of a confirmatory Phase 3 clinical trial for the treatment of acute GI GVHD and an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention of acute GVHD. Soligenix is also conducting an NIH-supported Phase 1/2 clinical trial of SGX201 in the prevention of acute radiation enteritis. Additionally, Soligenix has a Lipid Polymer Micelle (LPM™) drug delivery technology for the oral
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
11. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... QC , Nov. 28, 2014 /CNW Telbec/ - Ergoresearch ... and known under the « Équilibre, orthèses et ... Ended on September 30, 2014. All dollar amounts in the ... for the first quarter of fiscal year 2015 ended this ... by 2,1 % compared to revenues of $ 4 227 942 ...
(Date:11/28/2014)... , Nov. 28, 2014 According to MedlinePlus, ... the course of their lifetime. For many, these pains are ... that is caused by a variety of factors. For those ... may be the best option. While there are a variety ... performed by Seyed M. Rezaian , M.D., Ph.D., F.R.C.S., ...
(Date:11/28/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... its wholly owned subsidiary, Valeant Pharmaceuticals International, will ... outstanding 6.875% Senior Notes due 2018, CUSIP Nos. ... 29, 2014 and has mailed an irrevocable notice ... approximately US$500 million aggregate principal amount of the ...
Breaking Medicine Technology:First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 2First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 3First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 44 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018 2
... NEW YORK, Dec. 16, 2010 Teach For America ... their partnership to advance math and science education in ... Foundation pledged $1.8 million to increase the number of ... America,s teaching corps by 2013.  This new grant brings ...
... VILLAGE, Colo., Dec. 16, 2010 Astrum Hearing Inc., an ... in no way affiliated with Astrum Marketing Inc., also known ... Chapter 7 bankruptcy pending in the Middle District of Florida. ... of the "Sears Hearing By Astrum" centers. Astrum ...
Cached Medicine Technology:Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools 2Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools 3Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing 2
(Date:11/28/2014)... Albany, NewYork (PRWEB) November 29, 2014 ... market, followed by Europe. The U.S. market is highly ... and ongoing researches in different clinical institutes such as ... developed markets, the Asia-Pacific region is expected to show ... and Rest of the World are poised to grow ...
(Date:11/28/2014)... November 29, 2014 Somax Performance ... analyzing, measuring and improving sports performance, is pleased ... have surpassed 3,000,00 views. The Institute, which works ... communities, improves performance far beyond conventional coaching and ... and Microfiber Reduction. , Many viewers have praised ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 ... Informatics has encouraged research in all the ... medicine, clinical decision support and population health ... integrates most recent innovation in machine learning, ... , View full report with full ...
(Date:11/28/2014)... 29, 2014 Lunadress.co.uk, one of the ... dresses, has recently released its fashionable white prom gowns. ... high quality and low price. The company provides a ... order, and free shipping for orders over 99 pounds. ... its professional sales representatives if needed. The kind experts ...
(Date:11/28/2014)... is a renowned women’s dress company. The company is ... for the global clients. Recently, iFitDress.com has announced its ... store. The new products are now provided at discounted ... sales manager of the company, the chic teal cocktail ... international market. , “We are happy to unveil ...
Breaking Medicine News(10 mins):Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 2Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 3Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 2Health News:Somax Sports Motion Analysis Videos Surpass 3,000,000 Views 3Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:Discounted Teal Cocktail Dresses From Famous Dress Supplier iFitDress.com 2
... , INDIANAPOLIS -- In recognition of his significant contributions ... investigator Malaz Boustani, M.D., MPH, associate professor of medicine ... the 2012 American Geriatrics Society Outstanding Scientific Achievement for ... the American Geriatrics Society annual meeting in Seattle in ...
... mainstay of diagnostic medicine since the late 19th century, ... Nevertheless, blood derived from the human umbilical cord has ... information, according to Rolf Halden, a researcher at Arizona ... appearing in the journal Environmental Health Perspectives , ...
... been issued to Moffitt Cancer Center for a computerized system ... trial. The newly patented system matches the registered patient,s own ... patient-donated biological tissue or tumor samples to the molecular ... the molecular level, and does it quickly. The system promises ...
... the field of Physical Anthropology. She not only holds ... Republic, but she is also the Chair of the ... Department of Genetics, Physical Anthropology and Animal Physiology of ... out numerous pieces of work into nutritional habits, life ...
... genetic mutation that gives them a high risk of several ... are damaged can,t repair any errors that occur in our ... Journal of Clinical Oncology , confirmed the increased risk ... including colon, uterus, ovary, kidney, stomach, and bladder cancers. ...
... 12 (HealthDay News) -- A best friend can help children ... a best friend present during an unpleasant event has an ... co-author William Bukowski, a psychology professor and director of the ... Montreal. "If a child is alone when he or she ...
Cached Medicine News:Health News:Geriatrician from Regenstrief Institute and Indiana University honored 2Health News:Following a trail of blood: A new diagnostic tool comes of age 2Health News:Following a trail of blood: A new diagnostic tool comes of age 3Health News:New Moffitt Cancer Center patent promises to accelerate cancer trials 2Health News:Analyzing the causes of obesity in the Romani ethnic group 2Health News:Analyzing the causes of obesity in the Romani ethnic group 3Health News:New analysis provides clearer picture of cancer risks associated with Lynch syndrome 2Health News:Best Friend Benefits Child's Mind, Body, Study Finds 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: